Actinium Pharmaceuticals, Inc.

Get Full Access

Description

  • Actinium Pharmaceuticals, Inc. (www.actiniumpharma.com) (NYSE MKT: ATNM) is a New York-based biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. Actinium's targeted radiotherapy is based on its proprietary delivery platform for the therapeutic utilization of alpha-emitting actinium-225 and bismuth-213 and certain beta emitting radiopharmaceuticals in conjunction with monoclonal antibodies. The Companys lead radiopharmaceutical candidate, Iomab-B, will be used in preparing patients for hematopoietic stem cell transplant, commonly referred to as bone marrow transplant. The Company is conducting a single, pivotal, multi-center Phase 3 clinical study of Iomab-B in patients with relapsed or refractory Acute Myeloid Leukemia (AML) who are over the age of 55 with a primary endpoint of durable complete remission of 6 months. The Companys second program, Actimab-A, will soon begin a Phase 2 trial for patients newly diagnosed with AML who are over the age of 60 in a single-arm multi-center trial.
  • location

    Headquarters:275 Madison Ave , New York, New York, United States

    More
  • Actinium Pharmaceuticals, Inc. phone

    Phone Number: +1 646-677-3800

  • Actinium Pharmaceuticals, Inc. website

    Website: https://www.actiniumpharma.com

  • Actinium Pharmaceuticals, Inc. employees

    Employees:40

  • Actinium Pharmaceuticals, Inc. revenue

    Revenue:$10 - 50M

  • Actinium Pharmaceuticals, Inc. legal name

    Legal Name:Actinium Pharmaceuticals, Inc.

  • Actinium Pharmaceuticals, Inc.'s Social Media

    Actinium Pharmaceuticals, Inc. linkedin Actinium Pharmaceuticals, Inc. facebook Actinium Pharmaceuticals, Inc. twitter
  • done Is this data correct?
  • |  NAICS Code: 541713  |

    Show More
Person level website identification

Chief Medical Officer for Actinium Pharmaceuticals, Inc.

Avinash Desai

Chief Medical Officer

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Avinash Desai

Chief Medical Officer

Steve O'loughlin

Chief Financial Officer

Jeffrey Chell

Board Member

Paul Diamond

Vice President, Patent And Legal Counsel

Qing Liang

Vice President, Head Of Radiation Sciences, Isotope Development And Supply Chain

Frequently Asked Questions regarding Actinium Pharmaceuticals, Inc.

  • Where are Actinium Pharmaceuticals, Inc.'s Headquarters?

    Actinium Pharmaceuticals, Inc.'s Headquarters are in 275 Madison Ave ,New York,New York,United States

  • What is Actinium Pharmaceuticals, Inc.'s phone number?

    Actinium Pharmaceuticals, Inc.'s phone number is +1 646-677-3800

  • What is Actinium Pharmaceuticals, Inc.'s official website?

    Actinium Pharmaceuticals, Inc.'s official website is https://www.actiniumpharma.com

  • What is Actinium Pharmaceuticals, Inc.'s Revenue?

    Actinium Pharmaceuticals, Inc.'s revenue is $10 - 50M

  • What is Actinium Pharmaceuticals, Inc.'s NAICS code?

    Actinium Pharmaceuticals, Inc.'s NAICS code is 541713

  • How many employees are working in Actinium Pharmaceuticals, Inc.

    Actinium Pharmaceuticals, Inc. has 40 employees

  • What is Actinium Pharmaceuticals, Inc.'s Industry?

    Actinium Pharmaceuticals, Inc. is in the industry of Biotechnology

  • Who is Actinium Pharmaceuticals, Inc.'s Chief Medical Officer?

    Actinium Pharmaceuticals, Inc.'s Chief Medical Officer is Avinash Desai

Company Directory